CLINICAL_TRIALS
trial_result
· 2017-06-29
Clinical Trial Update: Staccato Loxapine in Agitated Patients With Bipolar Disorder [Phase 3]
Summary
Phase 3 clinical trial of Staccato Loxapine for agitation in Bipolar I Disorder has completed and results have been posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Alexza Pharmaceuticals, Inc. | Conditions: Bipolar I Disorder | Phase 3 | Status: COMPLETED | Results posted: 2017-06-29